Acorda Therapeutics Statistics Share Statistics Acorda Therapeutics has 1.24M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 1.24M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 1.22M Failed to Deliver (FTD) Shares 5,001 FTD / Avg. Volume 3.98%
Short Selling Information The latest short interest is 8.1K, so 0% of the outstanding
shares have been sold short.
Short Interest 8.1K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 2.34
Valuation Ratios The PE ratio is -0.01 and the forward
PE ratio is null.
Acorda Therapeutics's PEG ratio is
0.
PE Ratio -0.01 Forward PE n/a PS Ratio 0.03 Forward PS n/a PB Ratio -0.02 P/FCF Ratio -0.22 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Acorda Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.33,
with a Debt / Equity ratio of -1.21.
Current Ratio 0.33 Quick Ratio 0.26 Debt / Equity -1.21 Debt / EBITDA 22.72 Debt / FCF -13.4 Interest Coverage -0.74
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $1.15M Profits Per Employee $-2.48M Employee Count 102 Asset Turnover 1 Inventory Turnover 2.85
Taxes Income Tax -43.17M Effective Tax Rate 14.58%
Stock Price Statistics The stock price has increased by -24.91% in the
last 52 weeks. The beta is 1.46, so Acorda Therapeutics's
price volatility has been higher than the market average.
Beta 1.46 52-Week Price Change -24.91% 50-Day Moving Average 1.48 200-Day Moving Average 2.07 Relative Strength Index (RSI) 45.91 Average Volume (20 Days) 125,680
Income Statement In the last 12 months, Acorda Therapeutics had revenue of 117.63M
and earned -252.85M
in profits. Earnings per share was -203.59.
Revenue 117.63M Gross Profit 71.59M Operating Income -23.26M Net Income -252.85M EBITDA 8.4M EBIT -233.49M Earnings Per Share (EPS) -203.59
Full Income Statement Balance Sheet The company has 30.36M in cash and 190.9M in
debt, giving a net cash position of -160.54M.
Cash & Cash Equivalents 30.36M Total Debt 190.9M Net Cash -160.54M Retained Earnings -1.19B Total Assets 81.58M Working Capital -175.48M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -13.98M
and capital expenditures -264K, giving a free cash flow of -14.25M.
Operating Cash Flow -13.98M Capital Expenditures -264K Free Cash Flow -14.25M FCF Per Share -11.47
Full Cash Flow Statement Margins Gross margin is 60.86%, with operating and profit margins of -19.78% and -214.95%.
Gross Margin 60.86% Operating Margin -19.78% Pretax Margin -251.65% Profit Margin -214.95% EBITDA Margin 7.14% EBIT Margin -19.78% FCF Margin -12.11%
Dividends & Yields ACOR does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ACOR.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jun 5, 2023. It was a
backward
split with a ratio of 1:20.
Last Split Date Jun 5, 2023 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -23 Piotroski F-Score 3
